Target intelligence / Profile preview

Ribosomal protein L18a pseudogene 3 (RPL18AP3)

Target: RPL18AP3
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L18a pseudogene 3 (RPL18AP3) is classified as a processed pseudogene in the human genome and does not encode a functional protein product. It is related in sequence to the gene encoding 60S ribosomal protein L18a, a structural component of the large ribosomal subunit, but lacks coding potential due to its pseudogene status. There are many such ribosomal protein pseudogenes in the genome, and they are not considered to function as therapeutic targets or encode active ribosomal proteins[2][3][4].

Other names: RPL18AP3RPL18A_6_1273bcm182

Beyond the preview

Go deeper on Ribosomal protein L18a pseudogene 3 (RPL18AP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L18a pseudogene 3 (RPL18AP3).

Explore the full profile